Nuzenio

Replimune Wins Fda

Replimune Wins Fda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. -- Barrons.com - MoomooMoomoo · Sat, 08 Aug 2026 00:16:29 GMT Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMT Is the biotech capital of the world moving? - STATSTAT · Fri, 07 Aug 2026 12:54:22 GMT Why Is REPL Stock Soaring 127% After Hours Today? - StocktwitsStocktwits · Fri, 07 Aug 2026 11:11:56 GMT Third time lucky for Replimune as FDA OKs melanoma drug - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 09:50:13 GMT US FDA approves Replimune’s skin cancer drug after prior rejections - WNWN-FMWNWN-FM · Fri, 07 Aug 2026 02:36:12 GMT Replimune wins on third try as FDA clears Tudriqev for melanoma - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 00:57:10 GMT Third time’s the charm for Replimune as melanoma drug earns FDA greenlight - BioSpaceBioSpace · Thu, 06 Aug 2026 22:18:12 GMT

Timeline

Sat, 08 Aug 2026 00:16:29 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. -- Barrons.com - Moomoo

Fri, 07 Aug 2026 19:33:00 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron's

Fri, 07 Aug 2026 12:54:22 GMTIs the biotech capital of the world moving? - STAT

Fri, 07 Aug 2026 11:11:56 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - Stocktwits

Fri, 07 Aug 2026 09:50:13 GMTThird time lucky for Replimune as FDA OKs melanoma drug - pharmaphorum

Fri, 07 Aug 2026 02:36:12 GMTUS FDA approves Replimune’s skin cancer drug after prior rejections - WNWN-FM

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Replimune28 live mentions FDA23 live mentions Third Try4 live mentions Why4 live mentions Stock Is Tumbling4 live mentions WNWN4 live mentions Tudriqev4 live mentions After4 live mentions Skin Cancer Drug3 live mentions Approval3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Replimune Wins Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.